ANALYST-UPGRADE filed Aug 21, 2026 at 05:47 ET
BMO Capital initiated coverage on Marvell Technology (MRVL) at Outperform with a $250 price target, essentially in line with the current price of $251.01. The call adds to an already bullish consensus: 42 of 49 analysts rate MRVL Buy or Strong Buy, 7 rate Hold, and none rate Sell. The mean price target is $259.91, implying ~3.5% upside, while the median is $247.50. BMO's 53% accuracy on 1,841 calls is slightly above average, and its average return of +2.3% per call is solid. The initiation is consensus-aligned and not contrarian, so the impact is moderate. EPS revisions have been positive, 23 upward revisions for the current quarter in the last 7 days, with no downward revisions. Insider selling is notable, with five C-suite sales totaling ~$9.8M over the past two months, but these are routine liquidity events. Institutional activity is mixed: two large funds trimmed significantly, while three added. The bottom line: BMO's initiation adds a fresh bullish voice to an already crowded bull case, but the flat PT offers no immediate catalyst for a breakout.